Sergio Castrejon-Castrejon
Overview
Explore the profile of Sergio Castrejon-Castrejon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
303
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Castrejon-Castrejon S, Martinez Cossiani M, Basterra Sola N, Romero Roldan J, Ibanez Criado J, Osca J, et al.
JACC Clin Electrophysiol
. 2024 Dec;
11(2):350-361.
PMID: 39708035
Background: The optimal radiofrequency application (RFa) parameters for safe and durable pulmonary vein isolation (PVI) are debated. High-power short-duration (HPSD) has been used as an alternative to conventional power delivery...
2.
Rigual R, Castrejon-Castrejon S, Fernandez-Gasso L, Garcia-Castro J, Rodriguez-Pardo J, Martinez-Cossiani M, et al.
J Am Heart Assoc
. 2024 Aug;
13(17):e036236.
PMID: 39206739
Background: Unknown cardioembolic sources are frequent causes of cryptogenic stroke. We analyzed the risk of atrial fibrillation (AF) or high burden of ectopic atrial activity (HBEA) in patients with cryptogenic...
3.
Castrejon-Castrejon S, Martinez Cossiani M, Jauregui-Abularach M, Basterra Sola N, Ibanez Criado J, Osca Asensi J, et al.
J Interv Card Electrophysiol
. 2023 Feb;
66(8):1889-1899.
PMID: 36807734
Background: Electrical isolation of pulmonary veins (PV) with high-power short-duration (HPSD) radiofrequency application (RFa) may reduce the duration of atrial fibrillation (AF) ablation, without compromising the procedural efficacy and safety...
4.
Caro-Codon J, Rey J, Iniesta A, Rosillo S, Castrejon-Castrejon S, Rodriguez-Sotelo L, et al.
Rev Port Cardiol
. 2022 Jul;
41(10):823-830.
PMID: 35784098
Background: Chronic use of Angiotensin-converting enzyme (ACE) inhibitors (ACEi) and aldosterone-receptor blockers (ARB) is not associated with worse outcomes in patients with COVID-19. However, evidence on the impact of their...
5.
Rey J, Merino Llorens J, Iniesta Manjavacas A, Rosillo Rodriguez S, Castrejon-Castrejon S, Arbas-Redondo E, et al.
Med Clin (Engl Ed)
. 2022 Jun;
158(12):586-595.
PMID: 35693916
Aims And Objectives: Statins have been proposed as potentially useful agents for modulating the host response in COVID-19. However, solid evidence-based recommendations are still lacking. Our aim was to study...
6.
Severo Sanchez A, Rey J, Iniesta A, Merino J, Castrejon-Castrejon S, Lopez-de-Sa E, et al.
Rev Port Cardiol
. 2021 Nov;
41(4):355-357.
PMID: 34840414
No abstract available.
7.
Caro-Codon J, Rey J, Buno A, Iniesta A, Rosillo S, Castrejon-Castrejon S, et al.
Med Clin (Engl Ed)
. 2021 Sep;
157(6):274-280.
PMID: 34568576
Background: Myocardial injury has been identified as a common complication in patients with COVID-19. However, recent research has serious limitations, such as non-guideline definition of myocardial injury, heterogenicity of troponin...
8.
Rey J, Merino Llorens J, Iniesta Manjavacas A, Rosillo Rodriguez S, Castrejon-Castrejon S, Arbas-Redondo E, et al.
Med Clin (Barc)
. 2021 Sep;
158(12):586-595.
PMID: 34511251
Aims And Objectives: Statins have been proposed as potentially useful agents for modulating the host response in COVID-19. However, solid evidence-based recommendations are still lacking. Our aim was to study...
9.
Caro-Codon J, Rey J, Buno A, Iniesta A, Rosillo S, Castrejon-Castrejon S, et al.
Med Clin (Barc)
. 2021 Apr;
157(6):274-280.
PMID: 33846001
Background: Myocardial injury has been identified as a common complication in patients with COVID-19. However, recent research has serious limitations, such as non-guideline definition of myocardial injury, heterogenicity of troponin...
10.
Caro-Codon J, Lip G, Rey J, Iniesta A, Rosillo S, Castrejon-Castrejon S, et al.
Europace
. 2021 Feb;
23(6):937-947.
PMID: 33564822
Aims: Age, sex, and cardiovascular disease have been linked to thromboembolic complications and poorer outcomes in COVID-19. We hypothesize that CHADS2 and CHA2DS2-VASc scores may predict thromboembolic events and mortality...